GEMINALLY DI-SUBSTITUTED NSAID DERIVATIVES AS ABETA 42 LOWERING AGENTS
展开▼
机译:公认的二取代NSAID衍生物,获ABETA 42降糖剂
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention encompasses compounds of Formula I (I) or pharmaceutically acceptable salts thereof, wherein A is the base molecule of a propionic acid or acetic acid NSAID, or a derivative thereof, X is -COSUB2/SUBH, 1H-tetrazol-5-yl or 2H-tetrazol-5-yl and RSUP1 /SUPand RSUP2 /SUPare each independently selected from the group consisting of: CSUB1-6/SUBalkyl and CSUB3-6/SUBcycloalkyl, as well as pharmaceutical composition comprising said compounds and methods of using said compounds. The compounds of the present invention lower the level of AbetaSUB42 /SUBand are therefore useful for preventing, delaying or reversing the progression of Alzheimer's Disease.
展开▼
机译:本发明包括式I(I)的化合物或其药学上可接受的盐,其中A是丙酸或乙酸NSAID的基础分子或其衍生物,X是-CO 2 SUB> H ,1H-四唑-5-基或2H-四唑-5-基和R 1 SUP>和R 2 SUP>各自独立地选自:C 1-6烷基和C SUB 3 -6环烷基以及包含所述化合物的药物组合物和使用所述化合物的方法。本发明的化合物降低了Abeta 42 SUB>的水平,因此可用于预防,延迟或逆转阿尔茨海默氏病的发展。
展开▼